A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum
Open Access
- 18 July 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), 5686
- https://doi.org/10.1038/s41598-017-05474-y
Abstract
Calciprotein particles, nanoscale aggregates of insoluble mineral and binding proteins, have emerged as potential mediators of phosphate toxicity in patients with Chronic Kidney Disease. Although existing immunochemical methods for their detection have provided compelling data, these approaches are indirect, lack specificity and are subject to a number of other technical and theoretical shortcomings. Here we have developed a rapid homogeneous fluorescent probe-based flow cytometric method for the detection and quantitation of individual mineral-containing nanoparticles in human and animal serum. This method allows the discrimination of membrane-bound from membrane-free particles and different mineral phases (amorphous vs. crystalline). Critically, the method has been optimised for use on a conventional instrument, without the need for manual hardware adjustments. Using this method, we demonstrate a consistency in findings across studies of Chronic Kidney Disease patients and commonly used uraemic animal models. These studies demonstrate that renal dysfunction is associated with the ripening of calciprotein particles to the crystalline state and reveal bone metabolism and dietary mineral as important modulators of circulating levels. Flow cytometric analysis of calciprotein particles may enhance our understanding of mineral handling in kidney disease and provide a novel indicator of therapeutic efficacy for interventions targeting Chronic Kidney Disease-Mineral Bone Disorder.This publication has 93 references indexed in Scilit:
- Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failureKidney International, 2013
- Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the MacrophagePLOS ONE, 2013
- Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography–tandem mass spectrometryAnalytical Biochemistry, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitroKidney International, 2011
- Outcomes Associated With Phosphorus Binders in Men With Non–Dialysis-Dependent CKDAmerican Journal of Kidney Diseases, 2010
- Fetuin-Mineral Complex Reflects Extraosseous Calcification Stress in CKDJournal of the American Society of Nephrology, 2010
- The macrophage scavenger receptor at 30 years of age: current knowledge and future challengesJournal of Lipid Research, 2009
- Phosphorus Binders and Survival on HemodialysisJournal of the American Society of Nephrology, 2009